BBVA

Stronger trading gains and accelerated cost of risk normalisation

30/04/21 -"The quarter was marked by the deconsolidation of the US operations, albeit the accretive impact on the capital position still has to be factored in. It enjoyed strong CIB revenues and accelerated ..."

PDF page sample
Pages
64
Language
English
Published on
30/04/21
Download
You may also be interested by these reports :
04/12/25
We have upgraded our EPS projections on Swedbank with the bulk of the upgrade occurring in 2025 (+20%), as our estimates were overly conservative for ...
03/12/25
Overall, Barclays (ADD ; UK) offers a more resilient and predictable investment case than in previous years, but with a more moderate upside ...
02/12/25
NWG has become the least cyclical UK bank, ahead of LLOY, following continued de-risking and an increase in cyclicality at LLOY. BARC and STAN, ...
25/11/25
Julius Baer’s interim statement to October describes a healthy progression when it comes to asset gathering (+8% to CHF520bn), balance sheet strength ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO